Propionic Acidemia is a recessive genetic disorder in which the body is not able to make certain parts of lipids (fat) and protein properly. It is also known as an organic acid disorder, which causes an unusual buildup of particular organic acids in the body.
LPI (LP Information)' newest research report, the “Propionic Acidemia Treat Industry Forecast” looks at past sales and reviews total world Propionic Acidemia Treat sales in 2022, providing a comprehensive analysis by region and market sector of projected Propionic Acidemia Treat sales for 2023 through 2029. With Propionic Acidemia Treat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propionic Acidemia Treat industry.
This Insight Report provides a comprehensive analysis of the global Propionic Acidemia Treat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propionic Acidemia Treat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Propionic Acidemia Treat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propionic Acidemia Treat and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propionic Acidemia Treat.
The global Propionic Acidemia Treat market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Propionic Acidemia Treat is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Propionic Acidemia Treat is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Propionic Acidemia Treat is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Propionic Acidemia Treat players cover Cardiva Grifols SA, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire and China Biologic Products Holdings, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Propionic Acidemia Treat market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Intravenous Glucose Fluid Therapy
Antibiotics
Intravenous Bicarbonate
Biotin Supplement
Others
Segmentation by application
Hospital Pharmacies
Retail Pharmacy
Online Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cardiva Grifols SA
CSL Behring
Octapharma AG
Sanquin
Kedrion SpA
Shire
China Biologic Products Holdings, Inc

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Propionic Acidemia Treat Market Size 2018-2029 2.1.2 Propionic Acidemia Treat Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Propionic Acidemia Treat Segment by Type 2.2.1 Intravenous Glucose Fluid Therapy 2.2.2 Antibiotics 2.2.3 Intravenous Bicarbonate 2.2.4 Biotin Supplement 2.2.5 Others 2.3 Propionic Acidemia Treat Market Size by Type 2.3.1 Propionic Acidemia Treat Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Propionic Acidemia Treat Market Size Market Share by Type (2018-2023) 2.4 Propionic Acidemia Treat Segment by Application 2.4.1 Hospital Pharmacies 2.4.2 Retail Pharmacy 2.4.3 Online Pharmacy 2.4.4 Others 2.5 Propionic Acidemia Treat Market Size by Application 2.5.1 Propionic Acidemia Treat Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Propionic Acidemia Treat Market Size Market Share by Application (2018-2023) 3 Propionic Acidemia Treat Market Size by Player 3.1 Propionic Acidemia Treat Market Size Market Share by Players 3.1.1 Global Propionic Acidemia Treat Revenue by Players (2018-2023) 3.1.2 Global Propionic Acidemia Treat Revenue Market Share by Players (2018-2023) 3.2 Global Propionic Acidemia Treat Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Propionic Acidemia Treat by Regions 4.1 Propionic Acidemia Treat Market Size by Regions (2018-2023) 4.2 Americas Propionic Acidemia Treat Market Size Growth (2018-2023) 4.3 APAC Propionic Acidemia Treat Market Size Growth (2018-2023) 4.4 Europe Propionic Acidemia Treat Market Size Growth (2018-2023) 4.5 Middle East & Africa Propionic Acidemia Treat Market Size Growth (2018-2023) 5 Americas 5.1 Americas Propionic Acidemia Treat Market Size by Country (2018-2023) 5.2 Americas Propionic Acidemia Treat Market Size by Type (2018-2023) 5.3 Americas Propionic Acidemia Treat Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Propionic Acidemia Treat Market Size by Region (2018-2023) 6.2 APAC Propionic Acidemia Treat Market Size by Type (2018-2023) 6.3 APAC Propionic Acidemia Treat Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Propionic Acidemia Treat by Country (2018-2023) 7.2 Europe Propionic Acidemia Treat Market Size by Type (2018-2023) 7.3 Europe Propionic Acidemia Treat Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Propionic Acidemia Treat by Region (2018-2023) 8.2 Middle East & Africa Propionic Acidemia Treat Market Size by Type (2018-2023) 8.3 Middle East & Africa Propionic Acidemia Treat Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Propionic Acidemia Treat Market Forecast 10.1 Global Propionic Acidemia Treat Forecast by Regions (2024-2029) 10.1.1 Global Propionic Acidemia Treat Forecast by Regions (2024-2029) 10.1.2 Americas Propionic Acidemia Treat Forecast 10.1.3 APAC Propionic Acidemia Treat Forecast 10.1.4 Europe Propionic Acidemia Treat Forecast 10.1.5 Middle East & Africa Propionic Acidemia Treat Forecast 10.2 Americas Propionic Acidemia Treat Forecast by Country (2024-2029) 10.2.1 United States Propionic Acidemia Treat Market Forecast 10.2.2 Canada Propionic Acidemia Treat Market Forecast 10.2.3 Mexico Propionic Acidemia Treat Market Forecast 10.2.4 Brazil Propionic Acidemia Treat Market Forecast 10.3 APAC Propionic Acidemia Treat Forecast by Region (2024-2029) 10.3.1 China Propionic Acidemia Treat Market Forecast 10.3.2 Japan Propionic Acidemia Treat Market Forecast 10.3.3 Korea Propionic Acidemia Treat Market Forecast 10.3.4 Southeast Asia Propionic Acidemia Treat Market Forecast 10.3.5 India Propionic Acidemia Treat Market Forecast 10.3.6 Australia Propionic Acidemia Treat Market Forecast 10.4 Europe Propionic Acidemia Treat Forecast by Country (2024-2029) 10.4.1 Germany Propionic Acidemia Treat Market Forecast 10.4.2 France Propionic Acidemia Treat Market Forecast 10.4.3 UK Propionic Acidemia Treat Market Forecast 10.4.4 Italy Propionic Acidemia Treat Market Forecast 10.4.5 Russia Propionic Acidemia Treat Market Forecast 10.5 Middle East & Africa Propionic Acidemia Treat Forecast by Region (2024-2029) 10.5.1 Egypt Propionic Acidemia Treat Market Forecast 10.5.2 South Africa Propionic Acidemia Treat Market Forecast 10.5.3 Israel Propionic Acidemia Treat Market Forecast 10.5.4 Turkey Propionic Acidemia Treat Market Forecast 10.5.5 GCC Countries Propionic Acidemia Treat Market Forecast 10.6 Global Propionic Acidemia Treat Forecast by Type (2024-2029) 10.7 Global Propionic Acidemia Treat Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Cardiva Grifols SA 11.1.1 Cardiva Grifols SA Company Information 11.1.2 Cardiva Grifols SA Propionic Acidemia Treat Product Offered 11.1.3 Cardiva Grifols SA Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Cardiva Grifols SA Main Business Overview 11.1.5 Cardiva Grifols SA Latest Developments 11.2 CSL Behring 11.2.1 CSL Behring Company Information 11.2.2 CSL Behring Propionic Acidemia Treat Product Offered 11.2.3 CSL Behring Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 CSL Behring Main Business Overview 11.2.5 CSL Behring Latest Developments 11.3 Octapharma AG 11.3.1 Octapharma AG Company Information 11.3.2 Octapharma AG Propionic Acidemia Treat Product Offered 11.3.3 Octapharma AG Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Octapharma AG Main Business Overview 11.3.5 Octapharma AG Latest Developments 11.4 Sanquin 11.4.1 Sanquin Company Information 11.4.2 Sanquin Propionic Acidemia Treat Product Offered 11.4.3 Sanquin Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Sanquin Main Business Overview 11.4.5 Sanquin Latest Developments 11.5 Kedrion SpA 11.5.1 Kedrion SpA Company Information 11.5.2 Kedrion SpA Propionic Acidemia Treat Product Offered 11.5.3 Kedrion SpA Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Kedrion SpA Main Business Overview 11.5.5 Kedrion SpA Latest Developments 11.6 Shire 11.6.1 Shire Company Information 11.6.2 Shire Propionic Acidemia Treat Product Offered 11.6.3 Shire Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Shire Main Business Overview 11.6.5 Shire Latest Developments 11.7 China Biologic Products Holdings, Inc 11.7.1 China Biologic Products Holdings, Inc Company Information 11.7.2 China Biologic Products Holdings, Inc Propionic Acidemia Treat Product Offered 11.7.3 China Biologic Products Holdings, Inc Propionic Acidemia Treat Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 China Biologic Products Holdings, Inc Main Business Overview 11.7.5 China Biologic Products Holdings, Inc Latest Developments 12 Research Findings and Conclusion